Institutional investors purchased a net $5.2 million shares of ILMN during the quarter ended December 2013 and now own 115.68% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 4.0 Million shares of Illumina Inc
VIKING GLOBAL INVESTORS LP Bought 1.7 Million shares of Illumina Inc
INVESCO POWERSHARES CAPITAL MANA... Bought 1.5 Million shares of Illumina Inc